The role of corticosterone (Cort), the immune system's major stress hormone, in the regulation of hematopoietic stem and progenitor cells (HSPCs) and their dynamic bone marrow (BM) microenvironment is currently unknown. We report that corticotropin-releasing factor receptor 1 (CRFR1) mutant mice with chronically low Cort levels showed aberrant HSPC regulation, having higher HSPC numbers and upregulation of the chemokine CXCL12, phenotypes that were restored by Cort supplementation. Expanded stromal progenitors known to support HSPCs were also observed in these low-Cort-containing mice. A similar phenotype was induced in wild-type (WT) mice by Metyrapone, a Cort synthesis inhibitor. Conversely, high Cort exposure induced HSPC apoptosis, reduced long-term BM repopulation and decreased stromal progenitor cell numbers. We documented circadian oscillations of Cort in WT BM but not in CRFR1 mutant mice, leading to diminished circadian BM CXCL12 fluctuations and increased number of circulating HSPCs in these mice. Finally, low Cort induced expansion of stromal progenitors, CXCL12 expression, HSPC proliferation and BM repopulation capacity, involving Notch1 signaling. This was associated with upregulation of the Notch ligand, Jagged1, in BM myeloid cells. Our results suggest that daily physiologic Cort oscillations are critical for balanced HSPC proliferation and function involving Notch1 signaling and their supportive BM microenvironment.
INTRODUCTION
Host defense depends on the continuous production of mature leukocytes, which together with other blood cells are the progeny of hematopoietic stem cells (HSCs). Leukocyte production in the bone marrow (BM) reservoir on demand is coordinated by dynamic interactions of the nervous and immune systems with the microenvironment. [1] [2] [3] [4] The BM microenvironment regulates HSPCs via signals from specialized stromal cells (i.e., reticular stromal mesenchymal stem and progenitor cells (MSPCs), osteoblastic, perivascular and endothelial cells) [5] [6] [7] [8] [9] [10] and the nervous system. 1, [11] [12] [13] [14] Emerging evidence demonstrate that the nervous system has a pivotal role in the regulation of HSPC migration and development. 3 Human HSPCs dynamically express receptors for catecholamines, which regulate their migration, proliferation and BM repopulation via Wnt signaling. 12 In addition, noradrenaline circadian rhythms regulate murine and human HSPC egress to the blood via daily fluctuations of the chemokine CXCL12 (SDF-1) and its major receptor CXCR4. 2 HSPCs dynamically react to various stress signals that regulate their proliferation and trafficking, 11, 15, 16 among which is Notch1, which was previously implicated in adult HSPC self-renewal and proliferation. 5, 17, 18 Notch1 signaling inhibits HSC differentiation, maintaining their primitive state, 19, 20 and is also involved in the proliferation and maintenance of various other types of stem cells. 21, 22 The physiologic secretion of the glucocorticoid (GC) corticosterone (Cort, the rodent equivalent of human cortisol), driven by the brain-controlled hypothalamic-pituitary-adrenal axis, also displays a typical light/darkness circadian pattern, thus resulting in high and low plasma concentrations during the day. 23 A myriad of clinical observations show that therapeutic doses of GC, the stressresponse-mediating agents and the major effectors of the immune system also have substantial effects on blood cells, inducing immune cell suppression. 24, 25 Response to GC stimuli is a cell-type-and dose-dependent feature. Although immature erythroblasts require GC for their expansion, 26 early lymphoid progenitors are negatively regulated by GC 27 (an attribute clinically used to the advantage of lymphoma patients), which is in contrast to that seen in their myeloid progenitor counterparts, which are unaffected by GC. 28 Murine lineage À /Sca-1 þ /c-Kit þ (LSK) primitive progenitors demonstrate higher resistance to GCinduced apoptosis than the more mature LSK/TdT cells with lymphocytic commitment. 27 However, the role of the major stress GC hormone, Cort, in murine HSPC regulation and the function of these primitive cells in chronic conditions of Cort excess or paucity are currently unknown.
The circadian availability pattern, marked upregulation following stress and bone-related effects suggest a potential major role for Cort in the regulation of HSPCs. We therefore sought to determine whether Cort regulates HSPCs, namely their proliferation and BM repopulation capacity. To address this question, we applied genetic and pharmacologic in vivo and in vitro murine models inducing low-and high-Cort conditions.
Here we report that low-Cort conditions triggered HSPCs and stromal progenitor proliferation involving Notch1 signaling, associated with a high CXCL12 production by reticular Nestin þ MSPCs. Conversely, chronically high Cort levels suppressed BM HSPC proliferation by inducing cell apoptosis and reducing their long-term repopulation (LTR) capacity. Our study demonstrates that balanced Cort production is crucial for the regulation of HSPC proliferation and function.
MATERIALS AND METHODS

Mice and in vivo treatment
All experiments were approved by the Weizmann Institutional Animal Care and Use Committee. C57BL/6 (CD45.2, Harlan, Rehovot, Israel), B6/SJL (CD45.1), CRFR1 WT and mutant mice 29 and Nestin-GFP knockin mice (kindly provided by Grigori Enikolopov (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA) 8, 30 were bred and maintained under defined flora conditions and at 12-h light-dark cycles, at the Weizmann Institute of Science. Eight-to ten-week-old mice were used in this study, nX5 mice/ group. The CD45 À /Nestin-GFP þ stromal cells in the BM of GFP þ TgN mice were shown to be more primitive than Nestin-expressing stromal cells identified by antibodies. MSPCs from these mice are therefore referred to herein as Nestin-GFP þ cells. Cort (Sigma-Aldrich, Rehovot, Israel) was dissolved in 95% ethanol and administered in the drinking water (25 or 50 mg/ml as indicated, 5 weeks) or injected subcutaneously (20 mg/kg/d dissolved in 2% DMSO and 1:50 in phosphate-buffered saline, 7 days). Metyrapone (Sigma) was dissolved in phosphate-buffered saline and injected intraperitoneally (100 mg/kg/day, 5 days). Three hours after the last injection of drugs or vehicles, mice were killed. For progenitor proliferation in vivo, mice were injected intraperitoneally with BrdU (2 mg/injection, Sigma) 12 and 24 h before killing. For circadian studies, mice were killed1 h before the dark phase (Zeitgeber Time, ZT11) or 1 h before the light phase (ZT23).
In vitro stimulation
Total BM cells or BM mononuculear cells (MNCs) (as indicated) were cultured in 12-well or 6-well plates (5-10 Â 10 6 cells/well per 2 or 3 ml, respectively) in RPMI supplemented with 10% fetal calf serum, 5% of glutamine, penicillin, streptomycin) for 2 or 24 h or for 4 days as indicated. Cultures were stimulated once on experiment onset with Cort (Sigma, 10
-Sphenylglycine t-butyl ester (DAPT) (Sigma, 50 mM), their vehicles or their combinations. DAPT doses were determined experimentally choosing the lower dose that did not affect cell viability and colony formation when added solely (data not shown).
Colony-forming assay (CFU-C)
Total BM cells were cultured in Dulbecco's minimal essential medium supplemented with 20% fetal calf serum without cytokine addition for 5 days and were then stimulated with vehicle or Cort for additional 4 days after medium refreshment. BM MNCs were incubated in RPMI supplemented with 10% fetal calf serum with no cytokine addition, in the presence of vehicle or Cort for 2 h. Cultured cells were washed and seeded in CFU-C semisolid medium supplemented with EPO, IL-3, GM-CSF and SCF as described. 31 
Homing
Total BM cells obtained from CRFR1 WT and mutant mice, or WT BM MNCs stimulated for 2 h with vehicle or low Cort, were transplanted into NOD/ SCID mice that were lethally irradiated 24 h before (600 cGy, 5 Â 10 6 cells/ mouse). Mice were killed 16 h later, one femur was flushed and a 1/3 of the volume was seeded in methyl cellulose cultures as described above.
Repopulation assay BM cells from either B6.SJL (CD45.1) mice receiving Cort in their drinking water or BM MNCs from untreated mice that underwent a 2-h low Cort stimulation in vitro were transplanted into lethally irradiated (1000 cGy) C57BL.6 (CD45.2) congenic mice (2 Â 10 5 donor cells with 4 Â 10 5 host cells). BM cells from CRFR1 WT and mutant mice were similarly transplanted into B6.SJL mice. BM transplantation was performed 24 h after irradiation. Mice were killed 1 month or 4 months later and the levels of donor chimerism were determined by flow cytometry using rat antimouse CD45.2/CD45.1 (eBioscience, San Diego, CA, USA).
Flow cytometry
Cells were stained using standard protocols and analyzed by FACSCalibur (BD Biosciences) or MacsQuant (Miltenyi, Bergisch Gladbach, Germany). Lineage-/ Sca-1 þ /c-Kit þ (LSK) cells were determined as described. 31 Stromal precursors were identified using rat anti-mouse CD11b-APC (eBioscience) and CD45-APC, CD29-FITC and Sca-1-PE (BioLegend, San Diego, CA, USA).
32
CXCR4 was stained with rabbit anti-rat CXCR4 (Torrey Pines Biolabs, Secaucus, NJ, USA) and CXCL12 with K15C mAb (IRNA). 31 Expression of Jagged1 by macrophages was determined by rat anti-mouse CD11b-FITC (Biolegend) and hamster anti-mouse Jagged1-PE (eBioscience). For intracellular staining, cells were permeabilized after extracellular staining using the cytofix/cytoperm kit (BD Biosciences). Intracellular staining included rabbit mAb anti-human glucocorticoid receptor (Epitomics, Burlingame, CA, USA), rabbit mAb and pAb anti-human-cleaved Notch1, Val1744 (Cell Signaling, Danvers, MA, USA), and secondary Ab included donkey anti-rabbit DyLight 405 (BioLegend). For the detection of Lin-/c-Kit þ progenitor proliferation, BM cells from BrdUinjected mice were first labeled with lineage markers and c-Kit, 31 permeabilized using a BrdU analysis kit and protocol (BD Bioscience) and stained using anti-BrdU-PE (BD).
Immunostaining CXCL12 DAB staining on bone sections was described. 31 Fluorescent staining of fixed CFU-F cultures seeded on coverslips (2 Â 10 6 c/w per 2 ml of a 24-well plate) (4% Paraformaldehyde, 10-30 min, room temperature) included blocking (7% horse serum), permeabilization (0.5% Triton X-100, Sigma) and second blocking (7% horse serum). Slides were stained with mouse anti-CXCL12 (K15C, INRA) followed by donkey anti-mouse488 (Alexa, Invitrogen, Molecular Probes, Eugene, OR, USA), goat anti-mouse Nestin (Santa Cruz Biotechnology, Santa Cruz, CA, USA, 1:100) followed by donkey anti-goat Rhodamine (Jackson ImmunoResearch, West Grove, PA, USA) and rabbit mAb anti-human-cleaved Notch1, Val1744 (Cell Signaling), followed by donkey anti-goat 488 (Jackson ImmunoResearch). Primary calvaria-derived osteoblasts from newborn mice were stained with rabbit mAb anti-cytoplasmic notch1 (Epitomics). Jagged1 was stained by rabbit anti-mouse Jagged1 (Santa cruz) and anti-rabbit Rhodamin Tritc (Jackson) before fixation. Myeloid cells were stained with CD11b-FITC (Biolegend). Slides were visualized and photographed using Olympus BX51 microscope and Olympus DP71 camera, Melville, NY, USA.
CFU-F and Nestin-GFP cells
Bones were flushed with freshly prepared medium: aMEM (Sigma), supplemented with 20% preselected fetal calf serum, 5% of L-glutamine/ penicillin/streptomycin and 5 mM sodium pyruvate (Biological Industries, Kibbutz Beit Haemek, Israel). Total BM cells (2.5 Â 10 6 /well/2 ml) were seeded in 12-well plates for 8 days with no medium change. For Nestin-GFP cells and clusters, cultures were stimulated for 8 days, visualized and photographed using inverted Zeiss Axiovert 200 microscope and Zeiss AxioCam MRm camera (LLC, Thornwood, NY, USA). For CFU-F quantification, wells were washed and fixed with Paraformaldehyde (4%) for 30 min in room temperature. After phosphate-buffered saline wash, wells were stained with methylen blue/eosin for 15 min in room temperature. CFU-F colonies were scored under inverted microscope. The assay was repeated three times in duplicates.
Reverse transcriptase-PCR Total RNA was extracted using TRI-Reagent (Sigma-Aldrich) according to the manufacturer's instructions. Two micrograms of total RNA was reverse transcribed using Moloney murine leukemia virus reverse transcriptase (Promega, Madison, WI, USA) and oligo-dT primers (Promega). Quantitative reverse transcribed-polymerase chain reaction (qRT-PCR) was performed using the ABI 7000 machine (Applied Biosystems, Grand Island, NY, USA) with SYBR Green PCR Master Mix (Applied Biosystems). Comparative quantification of transcripts was assessed with respect to hypoxanthine phosphoribosyl transferase (HPRT1) levels and amplified with appropriate primers. Primer sequence: mouse Notch1: forward 5 0 -GGAGTGGACGGGT CAGTACTGT-3 0 , reverse 5 0 -GCCGCCGTGTGTGTTGT-3 0 ; mouse Hes1: forward
Corticosterone EIA kit
The corticosterone EIA kit was obtained from Cayman Chemical Company (Ann Arbor, MI, USA) and was used as instructed by the manufacturer. 
RESULTS
Abnormal CXCL12 circadian rhythms and HSPC egress from the BM under chronic low-Cort conditions In order to understand whether Cort has a role in HSPC regulation in the context of the BM microenvironment, we looked for a murine model with aberrant Cort production. CRFR1 mutant mice have chronically low amounts of Cort in their plasma due to the depletion of CRFR1, a receptor for corticotropin-releasing factor, which mediates adrenal Cort production. Particularly, these mice lack the characteristic diurnal rise in circulating Cort. 29 As mice are nocturnal animals, Cort secretion peaks daily before sunset and the onset of the active period. Accordingly, Cort drops down to its nadir before sunrise. 33 Although plasma Cort levels are well documented, BM levels have not been reported. First, we measured Cort in BM fluids of WT mice and revealed a pattern similar to the pattern documented in the plasma, namely, high levels before the active period (Zeitgeber Time, ZT11, 1 h before the dark phase) and lower levels before sleep (ZT23, 1 h before the light phase). In contrast, CRFR1 mutant mice had only low Cort amounts lacking oscillations (Figure 1a) .
HSPC release to the circulation is guided by sympathetic circadian signals and CXCL12-related fluctuations in the BM. 13 To understand whether Cort and CXCL12 have a regulatory cross talk, we tested how CXCL12 expression and HSPC release take place in mice with abolished Cort oscillations. We found that, although WT mice expectedly showed oscillating amounts of BM CXCL12 with an evening (ZT11) climax and morning (ZT23) nadir, CRFR1 mutant mice showed persistently increased high CXCL12 levels lacking the undulating pattern (Figure 1b) . Moreover, WT mice exhibited the expected negative correlation between BM CXCL12 concentration and circulating leukocytes, demonstrating reduced egress when high CXCL12 levels in the BM, providing HSPCs with retention signals. Interestingly, despite their constant higher CXCL12 BM levels, CRFR1 mutant mice had more circulating leukocytes (Figure 1c) , colony-forming progenitor cells-CFU-C (Figure 1d ) and primitive LSK cells (Figure 1e) , showing impaired oscillations.
These data suggest that balanced daily oscillating Cort levels control CXCL12 circadian rhythms, which are crucial for normal HSPC egress as part of homeostasis. HSPC trafficking to the blood is guided by signals from the BM microenvironment. 3 Hence, to better understand whether Cort modulations affect HSPC also via their microenvironment, we further scrutinized the BM of CRFR1 mutant mice.
HSPC proliferation is induced by low-Cort systemic signals CRFR1 mutant mice had higher levels of CFU-C and LSK cells in their BM (Figures 2a-c, respectively) . To confirm that Cort paucity had indeed a casual effect on HSPC proliferation, we supplemented mice with Cort in their drinking water, using doses previously reported to re-acquire baseline levels. 29 We found that the WT phenotype of both CFU-C and LSK HSPC was restored by Cort supplementation. However, WT mice receiving the same treatment, demonstrated a suppressive effect by prolonged high Cort doses (Figures 2a and b) . A similar trend of LSK cell expansion was observed in the BM of WT mice injected with Metyrapone (Figure 2d ), a Cort synthesis inhibitor mimicking low-Cort conditions. To evaluate HSPC proliferation status, WT and CRFR1 mutant mice were injected with BrdU to label dividing cells. BM Lin-/c-Kit þ mutant progenitors showed higher proliferation rates (Figure 2e ). The higher ratio of CD34 À and reactive oxygen species (ROS low ) cells within the LSK cell population (Figures 2f and g respectively) hint for expanded population of functional HSCs. Indeed, transplantation experiments showed that the mutant BM cells gave rise to higher engraftment levels in both 1-month (short-term) and 4-month (long-term) repopulation assays (Figure 2h) . Similarly, a homing assay in which equal numbers of BM cells are transplanted into recipient mice demonstrated the higher frequency of progenitors in the BM of mutant donor mice in comparison with WT littermates (Figure 2i ). Realizing the impact of low and high Cort levels on proliferation of LSK progenitors, we next asked whether these primitive cells can directly respond to Cort stimuli. To exert its functions, Cort binds the widely expressed cytosolic GC receptor. 24 First, we documented the expression of glucocorticoid receptors in BM LSK cells from WT mice and found a positive expression as expected (Figure 2j ). We next asked whether these receptors transmit signals with physiologic relevance to HSPC function. As Cort levels vary along the day and are robustly enhanced following stress, low and high doses for in vitro studies were experimentally determined. A concentration of 10 À 8 M (referred to as 'low') was chosen as the dose with optimal proliferative effects that were not observed using higher Cort molarities, whereas a concentration of 10 À 5 M (referred to as 'high') was found to be the upper limit in toxicity and cell viability (data not shown). To address this question, we stimulated BM cells in vitro with low and high Cort doses and quantified the primitive LSK progenitors and their colony-forming activity. Phenotypically, low Cort exposure could not expand LSK cells within 24 h, whereas high Cort doses reduced the amounts of these primitive progenitors (Figure 2k) . However, functionally, a 4-day stimulation with low Cort doses enhanced the clonogenic potential reflecting a proliferative effect, whereas high Cort doses exerted a suppressive effect on colonyforming progenitors (Figure 2l ). This suppressive effect was eventually dose dependently induced by apoptosis (Figure 2m) . Accordingly, the LTR capacity of BM HSCs was also reduced following a chronic in vivo exposure of WT mice to high Cort doses (Figure 2n ). Given the implicated role of the CXCL12/CXCR4 axis in HSPC regulation, we next investigated the status of this axis in the CRFR1 mutant mice.
Increased CXCL12 and reduced CXCR4 expression in low-Cort microenvironment The levels of CXCL12 concentrations in the BM of CRFR1 mutant mice were higher in comparison with their WT counterparts. These could be restored to basal levels by Cort supplementation (Figure 3a) , with a similar trend in the peripheral blood (data not shown). Mutant mice differed also with regard to the chemokine levels bound to osteoblastic cells covering bone trabecules (Figure 3b ), a region with high HSPC content. 5, 34 A similar trend of CXCL12 upregulation was also found in WT mice treated with Metyrapone to reduce Cort levels in vivo (Figure 3c) . Interestingly, surface CXCR4, which is downregulated by high ligand concentrations, was expressed to a lower extent by CRFR1 mutant BM progenitors (Figures 3d and e) . To test whether lowCort conditions might mediate CXCR4 downregulation, in vitro BM cell cultures were conducted. Indeed, low Cort (10 À 8 M) reduced surface CXCR4 expression within 24 h (Figure 3f ).
These data demonstrate that exposure to low Cort skews HSPCs toward a proliferative state.
The results support the aforementioned in vivo findings suggesting that low Cort imparts HSPCs with enhanced proliferation potential, which was shown to be associated with reduced CXCR4 expression, 7, 35 whereas high Cort concentrations trigger suppressive effects leading to apoptosis. To elucidate a possible mechanism by which Cort may act to delay HSPC differentiation, we referred to Notch, a signaling pathway previously associated with adult HSC proliferation and self-renewal when overexpressed. 17, 19, 20, 36 Low-Cort-induced proliferation of HSPC is mediated by Notch1 signaling We next examined transcription of Notch1 and its target gene Hes1 in the BM of CRFR1 mutant mice and found higher levels of both transcripts as compared with WT littermates (Figures 4a and  b, respectively) . When Cort was supplemented exogenously, Notch1 expression was downregulated in the mutant mice and further suppressed in WT mice, demonstrating a pattern corroborating the related modulations in HSPC and CXCL12. Interestingly, we found that Notch1 and HES1 transcriptions also oscillate in a circadian manner (Figure 4c ), when at the same time point of low Cort production (Figure 1a) , these genes are highly transcribed and vice versa. The involvement of Notch in HSPC proliferation was also demonstrated in vitro. Notch signaling is initiated upon cleavage by g-secretase. 37 Simultaneous addition of DAPT, a g-secretase inhibitor, to BM cells stimulated with low Cort for only 2 h was sufficient to block Cort-mediated hematopoietic progenitor proliferation (Figure 4d ). Notably, a 2-h stimulation with low Cort did not affect the ratio of progenitors homing to the BM of recipient mice (Figure 4e ), nor the levels of short-term repopulating cells (Figure 4f ). However, this brief stimulation increased engraftment levels in a 4-month repopulation assay, an effect also abrogated by DAPT addition (Figure 4g ). These differences demonstrate that a 2-h stimulation with low Cort in vitro is sufficient to initiate the proliferation signals in long-term repopulating cells.
To document Notch cleavage, we used a monoclonal antibody specific for Val1744, the cleavage site of Notch1 intracellular domain (NICD), an event indicative for Notch1 signaling. 37 A 2-h stimulation of WT BM cells with low Cort was sufficient to induce Notch1 intracellular domain cleavage in primitive LSK cells (Figures 4h and i) . A polyclonal antibody for the same cleavage site demonstrated similar results (data not shown). This rapid effect suggests that a direct activation of Notch signaling by low Cort in HSPC may exist, which has yet to be elucidated. Macrophages and other myeloid precursors have been implicated in HSC regulation. [38] [39] [40] [41] BM macrophages express Jagged1 under growth factor regulation. 42 We therefore monitored expression of Jagged1 by myeloid cells exposed to low Cort microenvironment and found it to be upregulated in CRFR1 mutant mice (Figure 4j) , although the levels of the myeloid cells did not change (data not shown). In vitro cultures supplemented with low Cort demonstrated increased Jagged1 expression by cells attached to Nestin-GFP þ MSPC clusters (Figure 4k ), which are Mac-1-expressing myeloid cells (Figure 4l) , suggesting Jagged1-mediated activation of Notch signaling. However, the emerging role of MSPC in HSPC regulation infers that Cort may also regulate HSPC via their supporting stromal microenvironment.
Notch1 signaling regulates low-Cort-induced proliferation of stromal progenitors In addition to HSPC, CRFR1 mutant mice had higher levels of mesenchymal precursors in their BM (Figure 5a ), suggesting that low Cort may also facilitate MSPC proliferation. CD45
À /Nestin-GFP þ stromal cells in the BM of GFP þ TgN mice constitute a primitive MSC compartment with high CXCL12 expression and HSC support. 8 In order to evaluate the effect of Cort modulation in vivo, these mice were injected with Metyrapone, in order to inhibit endogenous Cort synthesis, or with high Cort to enforce its elevation. BM stromal cultures from Metyrapone-injected mice (Figures 5d-f ) and stromal progenitors (Figure 5g ), which could be blocked by DAPT (Figures  5f and g ), demonstrating a regulatory role for Notch signaling in this proliferative effect. Accordingly, Notch1 intracellular domain nuclear translocation in primary calvaria osteoblasts (Figure 5h ) and Notch1 signaling in Nestin-GFP þ stromal cells indicated by immunostaining of Notch1 intracellular domain cleavage-site Val1744 (Figure 5i ) were upregulated in low-Cort-stimulated cultures.
Collectively, our results suggest that low-Cort stimulation acts directly on HSPCs and indirectly via stromal precursors and myeloid cells to increase HSPC proliferation via Notch1 signaling without inducing their differentiation. Low Cort initiates Notch1 signaling to expand Nestin þ stromal precursors in the BM that support HSPCs via CXCL12 production. Upregulation of Jagged1 expression by myeloid cells may also facilitate Notch1 signaling in the low-Cort-exposed HSPCs. In parallel, HSPC proliferation may be initiated directly in a Notch1-dependent manner. Daily Cort oscillations are crucial for balancing HSPC and stromal precursor proliferation and differentiation in order to maintain a supportive microenvironment and optimal hematopoiesis.
DISCUSSION
Our study outlines a new regulatory role for Cort, the pivotal effector of the physiological stress response, in balancing murine HSPCs and their BM stromal supporting cells in steady state and Cort-associated stress conditions, within the circadian context. We showed that BM circadian Cort oscillations translate into CXCL12 fluctuations and consequent alterations in HSPC egress. HSPCs express the Cort receptor GR and differentially respond to varying Cort levels, whereas low and high concentrations induced proliferation and apoptosis, respectively. We also showed that alterations in Cort levels have a marked impact on LTR capacity following HSPC transplantation. Furthermore, low-Cort conditions increased proliferation of Nestin-GFP þ MSPC and CXCL12 expression. Finally, we demonstrated that Notch1 signaling mediated the observed Cort effects on HSPCs and stromal Nestin-GFP þ MSPCs. CXCL12/CXCR4 interactions are pivotal regulators of HSPCs. 43 Exposure of BM HSPCs to high CXCL12 concentrations inhibits their cell cycle progression, 35 whereas loss of BM-stroma-secreted CXCL12 deteriorates their LTR capacity. 44 Another example is the inducible depletion of CXCR4 in adult HSPCs, which promotes their proliferation and cell cycle entry. 7, 35 These studies demonstrate that a constant bias of CXCL12 production and interference of CXCL12/CXCR4 interactions in the BM are destructive to HSPCs. Normally, both CXCL12 13 and CXCR4 45 oscillate as part of physiologic HSPC regulation; however, CXCR4 oscillation is controlled by clock genes and not by circadian rhythms. 45 In normal homeostatic conditions, CXCL12 circadian fluctuations precede the HSPC egress from the BM, 13 resembling secretion of CXCL12 in AMD3100-induced rapid mobilization. 10 We found that a constantly high CXCL12 production, resulted by chronically low Cort levels and its imbalanced rhythms, severely damages HSPC compartment exchange. These abnormal egress rates may stem from the strong reduction in CXCR4 expression, which leads to their lower responsiveness to CXCL12 signals. Controlling CXCL12 fluctuations, Cort circadian rhythms are likely to act upstream to CXCL12. This notion is also supported by Cort supplementation to CRFR1 mutant mice, in which CXCL12 levels were restored. Thus, our findings suggest that balancing HSPC self-renewal, proliferation and quiescence requires Cort-oriented physiologic oscillations, as part of the dynamic niche signals.
A cell-type-and dose-dependent response to GC is well recognized. 26, 27 Detrimental effects of chronic stress on the hematopoietic system are also well established; however, stress duration is a key element. Chronic stressors are deleterious to immune function, but very brief stressors might even enhance immunity. 25 We found a higher LTR capacity of BM cells exposed to low Cort, demonstrating that undifferentiated HSPCs are highly responsive to low-Cort stimulus. Of note, vulnerability to GCinduced apoptosis can be hindered with microenvironmental protection by stromal cells. 27 Hence, by reducing BM Cort levels in vivo or by providing low-Cort stimulation to cultures in vitro, we could expand Nestin-GFP þ MSPCs, which have been previously designated also as HSC-niche supporting cells. 8 Interestingly, human and mouse BM MSPCs with niche-forming capacities express high levels of CXCL12. 4, 7, 8, 46 Thus, low-Cort-induced MSPC expansion with increased CXCL12 expression may explain the observed HSPC proliferation in our models. In support, recent studies demonstrate that reducing GR-signaling in vitro by a specific antagonist induces human MSPC proliferation, 47 and adding low dexamethasone concentrations to cocultures of mouse HSPC/MSPC induces their proliferation. 48 Interestingly, GC signaling resets circadian genes in peripheral tissues, acting directly in fibroblasts, 49 which demonstrate the role of GC in tissue regulation also in a non-circadian context. Notch1 and its target gene Hes1 are also transcribed in a circadian manner, when at the same time point of low Cort production, these genes were highly transcribed and vice versa. Notch1 inhibits HSC differentiation 5, 17, 19, 20 and is also implicated in proliferation and maintenance of various other types of stem cells, 21, 22 although this pathway, when knocked out, was shown to be dispensable for adult murine HSC development. [50] [51] [52] [53] We found that, despite minute expression of this receptor in steady state, low-Cort stimulation initiated Notch1 cleavage and signaling along with facilitation of HSPC proliferation and LTR capacity, both of which could be impaired by g-secretase inhibition. The same levels of physiologic low Notch1 signaling were demonstrated by different antibodies, resembling similar low levels reported by others. 5, 54 This low-Cort-mediated Notch1 signaling may be initiated by Jagged1-upregulation in myeloid cells, or directly in HSC, in an unknown yet mechanism. The rapid effect of low Cort on BM MNCs suggests the existence of such a route. Still, excess Cort supplementation reduced Notch1/Hes1 transcription in vivo and suppressed HSPC proliferation and LTR, apparently involving apoptosis. In line with our results, Notch1 is expressed to higher levels in lineage-negative murine BM cells with low ROS levels, whereas the high ROS-expressing immature cells demonstrate reduced Notch1 expression. 55 Resembling our results, the ROS low / Notch1 high phenotype is associated with high LTR capacity. 55 Intriguingly, BM progenitors from Fx À / À mice with Notch O-fucosylation defect display reduced self-renewal capability in 
